期刊文献+

终末期肾功能衰竭患者血清中HO-1、IL-6等在血液透析前后的改变

Changes of HO - 1, IL - 6 level in ESRD patients pre - and post - hemodialysis
下载PDF
导出
摘要 目的探讨终末期肾衰患者血液透析前后血红素氧化酶-1(HO-1)与白细胞介素-6(IL-6)、脂质过氧化物丙二醛(MDA)、同型半胱氨酸(Hcy)等指标的水平变化及相互之间的关系。方法自动生化分析仪测定血红蛋白、尿素氮、肌酐浓度;采用ELISA方法定量测定血清HO-1、IL-6,硫代硫巴比妥酸比色法测定MDA,荧光偏振法测定Hcy。结果终末期肾衰患者透析前HO-1、IL-6、MDA、Hcy水平明显升高,与对照组相比差异有统计学意义(P〈0.01);血液透析治疗前后上述指标水平均有明显改变,血清HO-1水平较透前升高(P〈0.01),IL-6、MDA、Hcy水平明显下降(P〈0.05)。结论血液透析能够提高终末期肾衰患者血清中HO-1水平,同时血液透析对IL-6、MDA、Hcy有一定的清除作用。 Objective To evaluate the effect of hemodialysis upon HO -1 ,IL- 6, Hcy level in ESRD patients pre -and post -henmodialysis. Methods The urea nitrogen and the blood creatinine level were estimated by automatic biochemistry analyzer ;HO - 1 ,IL- 6 level was measured by EHSA;MDA was measured by TBA;FPIA was used to quantitate Hcy. Results The HO - 1 ,IL -6,MDA,Hcy level in ESRD patients were up -regulated obviously compared with the control group;Mter the treatment of hemodialysis,the above index show up change evidently,HO- 1 value were up- regulated and IL-6,MDA,Hcy value were down- regulated significantly, Candusion Hemodialysis can elevate HO -1 level and lower IL-6,MDA,Hcy level in ESRD patients.
机构地区 解放军
出处 《中原医刊》 2007年第16期6-8,共3页 Central Plains Medical Journal
  • 相关文献

参考文献13

二级参考文献120

  • 1MIN ZHANG, BAO HuI ZHANG, LI CHEN, WEI AN1 Institute of Sports Medicine, The Third Hospital, Peking University, Beijing 100083, China 2Department of Cell Biology, Capital University of Medical Sciences, Beijing 100054, China.Overexpression of heme oxygenasel protects smooth muscle cells against oxidative injury and inhibits cell proliferation[J].Cell Research,2002,12(2):123-132. 被引量:16
  • 2[1]Yeun JY, Levien RA. C-reactive protein supereedes albumin in predicting mortality in hemodialysis patients AM J Kidney Dis, 2000, 35(5) :469-476
  • 3[2]Iain C. Macdougall and Angela C. Cooper. Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines. Nephrol Dial Transplant, 2002,17(2) :139-143
  • 4[3]Mclntyre C, Harprel, Macdougall IC,et al. Serum C-reactive protein as a markerfor infection and inflammation in regular dialysis patients.Clin Nephrol, 1997, 48(6): 327-338
  • 5[4]Harris TB, Ferruccl L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly.Am J Med, 1999,106(4): 506-512
  • 6[5]George A.Kaysen,Joel A. Dubin, Hans G.Muller, et al. The acutephase response varies with time and predicts serum albumin levels in hemodialysis patients. Kidney Int,2000, 58(4) :346-352
  • 7[6]Kaysen GA, Dubin JA,Muller HG,et al. Levels of alpha acid glycoprotein and ceruloplasmin predict future albumin levels in hemodialysis patients. Kidney Int, 2001, 60(12) :2360-2366
  • 8[7]Sitter T, Bergner A, Schiffl H. Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients.Nephrol Dial Transplant, 2000, 15(11) :1207-1211
  • 9[8]Schouten WE, Groote MP, Houte AJ, et al. Effect of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis.Nephrol Dia Transplant, 2000, 15(3):379-385
  • 10[1]laude L,Philippe C,Wahsou D,et al.Procalcitonin:a new marker of inflammation in hemodialysis patients.Nephrol Dial Transplant.2001,16(9):980~982.

共引文献222

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部